Labshake search
Citations for R&D Systems :
301 - 350 of 3632 citations for 6 Chloro 4 hydroxy 3 methoxycarbonyl 2H thieno 2 3 e 1 2 thiazine 1 1 dioxide since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Developmental Biology 2020Quote: ... supplemented with BMP4 (3 ng/ml, R&D Systems) and Thiazovivin (2 μM ...
-
bioRxiv - Synthetic Biology 2021Quote: ... and 3 μM GSK3 inhibitor (R&D Systems, CHIR99021). mESC medium was made from Knockout DMEM (Gibco 10829018) ...
-
bioRxiv - Immunology 2020Quote: ... LAG-3 (Polyclonal, R&D Systems, Minneapolis, MN, USA), CD123 (clone 7G3) ...
-
bioRxiv - Bioengineering 2021Quote: ... 20ng/mL IL-3 (R&D Systems 203-IL), 20 ng/mL G-CSF (R&D Systems 214-CS) ...
-
bioRxiv - Bioengineering 2021Quote: ... 0.01µg/mL IL-3 (R&D Systems, 203-IL) and 0.005µg/mL TNFα (R&D Systems ...
-
bioRxiv - Cell Biology 2021Quote: ... with 20 ng/ml rmIL-3 (R&D Systems), 50 ng/ml Flt3-Ligand (R&D Systems ...
-
bioRxiv - Genetics 2019Quote: ... and 3 μM GSK3 inhibitor (R&D Systems, CHIR99021). mESC medium was made from Knockout DMEM (Gibco 10829018) ...
-
bioRxiv - Cancer Biology 2020Quote: ... anti-cleaved caspase 3 were from R&D Systems.
-
bioRxiv - Neuroscience 2023Quote: ... 10ng/mL NT-3 (R&D Systems 267-N3), 100 ng/mL IGF (R&D Systems ...
-
bioRxiv - Neuroscience 2023Quote: ... 10ng/mL NT-3 (R&D Systems 267-N3), 100 ng/mL IGF (R&D Systems ...
-
bioRxiv - Developmental Biology 2022Quote: ... 3 ng/ml rhBMP4 (R&D Systems, #314-BP), and 3 ng/ml rmWNT3a (R&D Systems ...
-
bioRxiv - Bioengineering 2023Quote: ... 8 μM GSK-3 inhibitor CHIR99021 (R&D Systems), 200 ng/ml fibroblast growth factor 9 (FGF9 ...
-
bioRxiv - Neuroscience 2023Quote: ... and 25 ng/ml rhIL-3 (R&D Systems). Macrophage precursor cells could be routinely harvested from dishes containing EBs every 6/7 days for up to 3/4 months ...
-
bioRxiv - Immunology 2024Quote: ... anti-LAG-3 (polyclonal goat IgG, R&D Systems), anti-PD-1 (cloneEH12.1 ...
-
Nanoparticle-delivered TLR4 and RIG-I agonists enhance immune response to SARS-CoV-2 subunit vaccinebioRxiv - Immunology 2022Quote: ... there were six mice per treatment and control group for a total of 78 mice in thirteen groups: (A) Seven vaccine groups included 1 μg of unformulated SARS-CoV-2 spike protein (R&D Systems, Cat# 10549-CV-100) delivered with adjuvanted NPs ...
-
bioRxiv - Molecular Biology 2024Quote: ... Resting or ADP (10 μM)-stimulated platelets (4 × 103/μL) were pretreated with the inhibitor hDcR3 (10 μg/mL, recombinant human decoy receptor 3 protein, R&D Systems) for 10 min and then allowed to adhere to the coated coverslips for 60 min at RT under normoxic or hypoxic conditions ...
-
bioRxiv - Neuroscience 2024Quote: ... Cells were passaged by dissociation in 0.5 mM EDTA every 3-4 days and resuspended in Essential 8 Medium supplemented with Y-27632 dihydrochloride (10 μM; Cat.#1254; R&D Systems). For CRISPR-Cas9 editing ...
-
bioRxiv - Bioengineering 2024Quote: ... Hydrogels (n=3) were incubated for 4 hours in a solution of FBS-free DMEM supplemented with 10% Resazurin dye (AR002, R&D Systems) at 37°C ...
-
bioRxiv - Cell Biology 2022Quote: ... CXCL1 levels were measured after 3 h and 6 h using the Human CXCL1/GROα DuoSet® ELISA kit (R&D Systems, Minneapolis, MN, USA) according to the manufacturer’s instructions ...
-
bioRxiv - Bioengineering 2022Quote: ... were coated with 4 μg ml-1 recombinant mouse IL-10 receptor alpha (R&D Systems) overnight at 4°C ...
-
bioRxiv - Neuroscience 2020Quote: ... followed by overnight incubation at 4°C in anti-β3 tubulin (1:100, R&D Systems). Sections were rinsed and incubated with goat-anti-mouse Alexa-488 (1:500 ...
-
bioRxiv - Cell Biology 2023Quote: ... Human VEGFR3/Flt-4 antibody (1:500, AF743) was obtained from R&D systems (Minneapolis, MN). Horse Radish Peroxidase (HRP ...
-
bioRxiv - Developmental Biology 2023Quote: Retinal explants were treated with 200 ng·mL-1 rmSlit-1 or 500 ng·mL-1 rmEphrinA5 (R&D Systems) diluted in warm culture medium for 20 minutes before fixation with 4% (w/v ...
-
bioRxiv - Neuroscience 2022Quote: ... and insulin-like growth factor-1 (IGF-1, R&D systems) were supplemented to the media changes for 10 days ...
-
bioRxiv - Neuroscience 2020Quote: ... goat anti-SRY-BOX 1 (SOX1) (1/500; R&D Systems; Cat ...
-
bioRxiv - Cell Biology 2022Quote: ... anti-Pecam-1 goat (1:200; AF3628; R&D Systems; IF), and anti-isolectin-B4 (1:200 ...
-
bioRxiv - Cell Biology 2022Quote: ... and R-spondin-1 (0.5 μg mL-1, R&D systems).
-
bioRxiv - Microbiology 2023Quote: ... 1 µg/mL recombinant human R-spondin-1 (R&D systems), 500 nM A83-01 (R&D systems) ...
-
bioRxiv - Microbiology 2023Quote: ... 1 µg/mL recombinant human R-spondin-1 (R&D systems), 500 nM A83-01 (R&D systems) ...
-
bioRxiv - Neuroscience 2023Quote: ... vascular cell adhesion molecule 1 (VCAM-1) (R&D systems, DY643), intercellular adhesion molecule 1 (ICAM-1 ...
-
bioRxiv - Physiology 2023Quote: ... anti-PECAM-1 antibody (goat, 1:400, R&D Systems, USA), anti-VEGFR2 (rabbit ...
-
bioRxiv - Immunology 2022Quote: ... human IL-2 ELISA (human IL-2 Quantikine ELISA kit, R&D systems, USA) and TNFα ELISA (human TNF-alpha quantikine ELISA kit ...
-
bioRxiv - Molecular Biology 2023Quote: Polystyrene microtiter plates were coated with 1 µg/ml recombinant SARS-CoV-2 spike protein produced in HEK293T cells (10549-CV-100, R&D Systems and Biotech, NE, MN, USA) while some plates were coated with 50 ng/ml SARS-CoV-2 S protein RBD or Biotinylated hACE2 (0.2 µg/ml ...
-
bioRxiv - Immunology 2022Quote: ... plated at 1-2×104 cells/well in 96 U-bottom plate and cultured for 3 – 6 days in cRPMI medium in the presence of IL-33 (R&D Systems, #3626, 50 ng/ml) or TSLP (R&D Systems ...
-
bioRxiv - Genomics 2023Quote: ... Primary antibodies (FUS 1:100 Santa Cruz Biotech sc-47711; ISL1 1:500 Abcam ab109517; OLIG2 1:100 R&D Systems AF2418; NFM 1:1000 Merck MAB1621) were added in 1% BSA and incubated at 4degC overnight ...
-
bioRxiv - Immunology 2021Quote: ... PIGF-2 (R&D systems) and Endoglin/CD105 (R&D systems ...
-
bioRxiv - Developmental Biology 2023Quote: ... 2-APB (R&D Systems), SKF96365 (Wako) ...
-
bioRxiv - Cancer Biology 2023Quote: ... Type 2 (R&D Systems) and plated on 8-chamber slides (Thermo Scientific).
-
bioRxiv - Immunology 2022Quote: ... Lipocalin-2 (R&D Systems) and high sensitivity TNF (Invitrogen ...
-
bioRxiv - Cancer Biology 2022Quote: ... miniloci in an endogenous IgH and Igκ knockout background (19,20) were immunized with recombinant human LAG-3–Fc protein (hLAG-3–hFc) (R&D Systems, Minneapolis, MN, USA), consisting of the extracellular domain of LAG-3 (Leu23-Leu450 ...
-
bioRxiv - Cancer Biology 2022Quote: ... incubated overnight at 4°C in the following primary antibodies: T-LCK (1:1000 R&D Systems), T-LCK (1:1000 Proteintech) ...
-
bioRxiv - Neuroscience 2021Quote: ... incubated for 5 days at 4°C with Car4 primary antibody (1:500, RRID:AB_10013483; R&D Systems), rinsed ...
-
bioRxiv - Neuroscience 2023Quote: ... Tissues were stained overnight at 4°C with mouse CD45 antibody (1:200; Af114, R&D Systems). The next day ...
-
bioRxiv - Neuroscience 2023Quote: ... The cells were labeled with anti-human SSEA-4 APC-conjugated antibody (1:100, R&D Systems) at 37°C for 30 minutes ...
-
bioRxiv - Neuroscience 2021Quote: ... supplemented with 3 nM Shh (1845-SH; R&D Systems), as used in Ohyama et al (2005 ...
-
bioRxiv - Microbiology 2020Quote: ... GM-CSF and IL-3 [all from R&D Systems]) ...
-
bioRxiv - Cell Biology 2021Quote: ... 5 ng/mL recombinant murine IL-3 (R&D Systems, and 5% stem cell factor-containing supernatant from CHO-KL cells for 4-6 weeks until maturation ...
-
bioRxiv - Bioengineering 2021Quote: ... and 3 U/mL EPO (R&D Systems 287-TC). Cells were cultured for 7 days followed EHT and assessed using by flow cytometry.
-
bioRxiv - Developmental Biology 2022Quote: ... we used a SMAD2/3 antibody (R&D systems, AF3797) in 2X10^6 hESCs that were treated with Activin for 2 h or 24 h with or without Wnt priming ...
-
bioRxiv - Molecular Biology 2019Quote: ... followed by treatment with 3 nM BMP4(R&D Systems), 50 pg/ml TGF-β1 (R&D Biosystems) ...